A Study Of Reducing Cardiovascular And Kidney Disease Risk After Hypertensive Disorders Of Pregnancy

Overview

About this study

The purpose of this study is to optimize risk prediction for cardiovascular, kidney, and metabolic (CKM) syndrome using electronic health record data at the time of delivery to target high-risk groups. Our overall hypothesis is that socioeconomic and pregnancy-specific features available at the time of delivery can predict future CKM progression.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • At least 30 years old

  • Postpartum women who have recently experienced Hypertensive Disorders of Pregnancy (HDP).

  • Must be a Mayo Clinic patient eligible to receive an electronic portal message after delivery.

  • Willingness to undergo laboratory and urine tests for CV risk stratification at 6 months postpartum.

Exclusion Criteria:

  • Participants younger than 30 years old.

  • Pregnancy History: Participants who did not recently experience Hypertensive Disorders of Pregnancy (HDP).

  • Participants who are not in the postpartum period.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/10/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

La Crosse, Wis.

Mayo Clinic principal investigator

Andrea Kattah, M.D.

Open for enrollment

Rochester, Minn.

Mayo Clinic principal investigator

Andrea Kattah, M.D.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions